CCL5 and diabetic kidney disease: Feng et al. investigated the potential use of C-C Motif Chemokine Ligand 5 (CCL5) and C-X-C Motif Chemokine Ligand 1 (CXCL1) mRNA levels in urinary sediment as prognostic biomarkers for diabetic nephropathy.